ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.

Anna Capsomidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.